Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2020 Oct 22;20(1):251.
doi: 10.1186/s12893-020-00914-5.

Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)

G Gallo  1   2 , S Di Saverio  3 , G Clerico  4 , A Sturiale  5 , M Manigrasso  6 , A Realis Luc  4 , M Trompetto  4 , G Sammarco  7 ; MeHAEMO Working Group
Collaborators, Affiliations
Clinical Trial

Mesoglycan for pain control after open excisional HAEMOrrhoidectomy (MeHAEMO): an observational multicentre study on behalf of the Italian Society of Colorectal Surgery (SICCR)

G Gallo et al. BMC Surg. .

Erratum in

Abstract

Background: Excisional haemorrhoidectomy is the gold standard technique in patients with III and IV degree haemorrhoidal disease (HD). However, it is associated with a significant rate of post-operative pain. The aim of our study was to evaluate the efficacy of mesoglycan in the post-operative period of patients who underwent open excisional diathermy haemorrhoidectomy (OEH).

Methods: This was a retrospective multicentre observational study. Three hundred ninety-eight patients from sixteen colorectal referral centres who underwent OEH for III and IV HD were enrolled. All patients were followed-up on the first post-operative day (T1) and after 1 week (T2), 3 weeks (T3) and 6 weeks (T4). BMI, habits, SF-12 questionnaire, VAS at rest (VASs), after defecation (VASd), and after anorectal digital examination (VASe), bleeding and thrombosis, time to surgical wound healing and autonomy were evaluated.

Results: In the mesoglycan group, post-operative thrombosis was significantly reduced at T2 (p < 0.05) and T3 (p < 0.005), and all patients experienced less post-operative pain at each time point (p < 0.001 except for VASe T4 p = 0.003). There were no significant differences between the two groups regarding the time to surgical wound healing or post-operative bleeding. There was an early recovery of autonomy in the mesoglycan group in all three follow-up periods (T2 p = 0.016; T3 p = 0.002; T4 p = 0.007).

Conclusions: The use of mesoglycan led to a significant reduction in post-operative thrombosis and pain with consequent early resumption of autonomy. Trial registration NCT04481698-Mesoglycan for Pain Control After Open Excisional HAEMOrrhoidectomy (MeHAEMO) https://clinicaltrials.gov/ct2/show/NCT04481698?term=Mesoglycan+for+Pain+Control+After+Open+Excisional+HAEMOrrhoidectomy+%28MeHAEMO%29&draw=2&rank=1.

Keywords: Haemorrhoidal disease; Mesoglycan; Mucocutaneous bridges; Open excisional haemorrhoidectomy; Post-operative pain; Thrombosis.

PubMed Disclaimer

Conflict of interest statement

The Authors declare that they have no competing interests. The Authors alone are responsible for the content and writing of the paper.

Figures

Fig. 1
Fig. 1
Post-operative bleeding
Fig. 2
Fig. 2
Post-operative thrombosis
Fig. 3
Fig. 3
Boxplot representing the physical score (PCS) distribution of the SF-12 questionnaire
Fig. 4
Fig. 4
Boxplot representing the mental score (MCS) distribution of the SF-12 questionnaire
Fig. 5
Fig. 5
Wound healing
See this image and copyright information in PMC

References

    1. Gallo G, Sacco R, Sammarco G. Epidemiology of hemorrhoidal disease. In: Ratto C, Parello A, Litta F, editors. Hemorrhoids coloproctology. Cham: Springer; 2018. pp. 3–7.
    1. Gallo G, Martellucci J, Sturiale A, Clerico G, Milito G, Marino F, et al. Consensus statement of the Italian society of colorectal surgery (SICCR): management and treatment of hemorrhoidal disease. Tech Coloproctol. 2020;24:145–164. doi: 10.1007/s10151-020-02149-1. - DOI - PMC - PubMed
    1. Cocorullo G, Tutino R, Falco N, Licari L, Orlando G, Fontana T, et al. The non-surgical management for hemorrhoidal disease. A systematic review. G Chir. 2017;38:5–14. doi: 10.11138/gchir/2017.38.1.005. - DOI - PMC - PubMed
    1. Ratto C, Campennì P, Papeo F, Donisi L, Litta F, Parello A. Transanal hemorrhoidal dearterialization (THD) for hemorrhoidal disease: a single-center study on 1000 consecutive cases and a review of the literature. Tech Coloproctol. 2017;21:953–962. doi: 10.1007/s10151-017-1726-5. - DOI - PMC - PubMed
    1. Schneider R, Jäger P, Ommer A. Long-term results after stapled hemorrhoidopexy: a 15-year follow-up. World J Surg. 2019;43:2536–2543. doi: 10.1007/s00268-019-05065-0. - DOI - PubMed